Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018

Objective. To describe the resistance profile and the genetic characteristics of Escherichia coli isolates that harbor the mobilizable colistin resistance gene mcr-1 in Argentina. Methods. This was a retrospective study of 192 E. coli isolates positive for mcr-1 obtained from 69 hospitals of Buenos...

Full description

Bibliographic Details
Main Authors: Diego Faccone, Melina Rapoport, Ezequiel Albornoz, Federico Celaya, Juan De Mendieta, Denise De Belder, Celeste Lucero, Sonia Gomez, Diego Danze, Fernando Pasteran, Alejandra Corso, Mobilizable Colistin Resistance Group
Format: Article
Language:English
Published: Pan American Health Organization 2020-09-01
Series:Revista Panamericana de Salud Pública
Subjects:
Online Access:https://iris.paho.org/handle/10665.2/52324
id doaj-0ca7e4cc7efd48348704fa31841da1b6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Diego Faccone
Melina Rapoport
Ezequiel Albornoz
Federico Celaya
Juan De Mendieta
Denise De Belder
Celeste Lucero
Sonia Gomez
Diego Danze
Fernando Pasteran
Alejandra Corso
Mobilizable Colistin Resistance Group
spellingShingle Diego Faccone
Melina Rapoport
Ezequiel Albornoz
Federico Celaya
Juan De Mendieta
Denise De Belder
Celeste Lucero
Sonia Gomez
Diego Danze
Fernando Pasteran
Alejandra Corso
Mobilizable Colistin Resistance Group
Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
Revista Panamericana de Salud Pública
drug resistance, multiple
colistin
enterobacteriaceae
escherichia coli
argentina
author_facet Diego Faccone
Melina Rapoport
Ezequiel Albornoz
Federico Celaya
Juan De Mendieta
Denise De Belder
Celeste Lucero
Sonia Gomez
Diego Danze
Fernando Pasteran
Alejandra Corso
Mobilizable Colistin Resistance Group
author_sort Diego Faccone
title Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
title_short Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
title_full Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
title_fullStr Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
title_full_unstemmed Plasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018
title_sort plasmidic resistance to colistin mediated by mcr-1 gene in escherichia coli clinical isolates in argentina: a retrospective study, 2012–2018
publisher Pan American Health Organization
series Revista Panamericana de Salud Pública
issn 1020-4989
1680-5348
publishDate 2020-09-01
description Objective. To describe the resistance profile and the genetic characteristics of Escherichia coli isolates that harbor the mobilizable colistin resistance gene mcr-1 in Argentina. Methods. This was a retrospective study of 192 E. coli isolates positive for mcr-1 obtained from 69 hospitals of Buenos Aires City and 14 Argentinean provinces in 2012 – 2018. The antimicrobial susceptibility was performed by agar diffusion, broth macrodilution, and/or agar dilution. Standard polymerase chain reaction (PCR) was performed to detect resistance genes and incompatibility groups; specific PCR was applied to discriminate between blaCTX-M allelic groups and mcr-1.5 variant. The genetic relatedness among isolates was evaluated by XbaI-pulsed field gel electrophoresis and multilocus sequence typing in a subset of isolates. Results. All E. coli isolates showed minimal inhibitory concentrations to colistin ≥ 4μg/mL; nearly 50% were resistant to third-generation cephalosporins, with CTX-M-2 being the main extended-spectrum β-lactamase detected. Five E. coli were carbapenemase-producers (3 NDM, 2 KPC). The mcr-1.5 variant was detected in 13.5% of the isolates. No genetic relationship was observed among the mcr-1-positive E. coli clinical isolates, but a high proportion (164/192; 85.4%) of IncI2 plasmids was detected. Conclusions. The presence of IncI2 plasmids among highly diverse E. coli clones suggests that the mcr-1 gene’s wide distribution in Argentina may be driven by the horizontal transmission of IncI2 plasmids.
topic drug resistance, multiple
colistin
enterobacteriaceae
escherichia coli
argentina
url https://iris.paho.org/handle/10665.2/52324
work_keys_str_mv AT diegofaccone plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT melinarapoport plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT ezequielalbornoz plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT federicocelaya plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT juandemendieta plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT denisedebelder plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT celestelucero plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT soniagomez plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT diegodanze plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT fernandopasteran plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT alejandracorso plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
AT mobilizablecolistinresistancegroup plasmidicresistancetocolistinmediatedbymcr1geneinescherichiacoliclinicalisolatesinargentinaaretrospectivestudy20122018
_version_ 1724443265989607424
spelling doaj-0ca7e4cc7efd48348704fa31841da1b62020-11-25T04:02:22ZengPan American Health OrganizationRevista Panamericana de Salud Pública1020-49891680-53482020-09-0144551810.26633/RPSP.2020.55rpspPlasmidic resistance to colistin mediated by mcr-1 gene in Escherichia coli clinical isolates in Argentina: A retrospective study, 2012–2018Diego Faccone0Melina Rapoport1Ezequiel Albornoz2Federico Celaya3Juan De Mendieta4Denise De Belder5Celeste Lucero6Sonia Gomez7Diego Danze8Fernando Pasteran9Alejandra Corso10Mobilizable Colistin Resistance Group11Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.National Council on Scientific and Technical Research (CONICET), Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.National Council on Scientific and Technical Research (CONICET), Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Antimicrobial Agents Division, National and Regional Reference Laboratory for Antimicrobial Resistance, National Institute on Infectious Diseases – ANLIS “Dr. Carlos G. Malbrán,” Buenos Aires, Argentina.Members are listed in the Acknowledgement at the end of the article.Objective. To describe the resistance profile and the genetic characteristics of Escherichia coli isolates that harbor the mobilizable colistin resistance gene mcr-1 in Argentina. Methods. This was a retrospective study of 192 E. coli isolates positive for mcr-1 obtained from 69 hospitals of Buenos Aires City and 14 Argentinean provinces in 2012 – 2018. The antimicrobial susceptibility was performed by agar diffusion, broth macrodilution, and/or agar dilution. Standard polymerase chain reaction (PCR) was performed to detect resistance genes and incompatibility groups; specific PCR was applied to discriminate between blaCTX-M allelic groups and mcr-1.5 variant. The genetic relatedness among isolates was evaluated by XbaI-pulsed field gel electrophoresis and multilocus sequence typing in a subset of isolates. Results. All E. coli isolates showed minimal inhibitory concentrations to colistin ≥ 4μg/mL; nearly 50% were resistant to third-generation cephalosporins, with CTX-M-2 being the main extended-spectrum β-lactamase detected. Five E. coli were carbapenemase-producers (3 NDM, 2 KPC). The mcr-1.5 variant was detected in 13.5% of the isolates. No genetic relationship was observed among the mcr-1-positive E. coli clinical isolates, but a high proportion (164/192; 85.4%) of IncI2 plasmids was detected. Conclusions. The presence of IncI2 plasmids among highly diverse E. coli clones suggests that the mcr-1 gene’s wide distribution in Argentina may be driven by the horizontal transmission of IncI2 plasmids.https://iris.paho.org/handle/10665.2/52324drug resistance, multiplecolistinenterobacteriaceaeescherichia coliargentina